#1 Clinical Trials Search in Europe
EU – Europe
AT – Austria
HR – Croatia
CZ – Czech Republic
DK – Denmark
EE – Estonia
FI – Finland
FR – France
DE – Germany
IS – Iceland
IT – Italy
LV – Latvia
LT – Lithuania
NL – Netherlands
NO – Norway
PL – Poland
PT – Portugal
RO – Romania
SK – Slovakia
SI – Slovenia
ES – Spain
SE – Sweden
  • Find a Clinical Trial

    Search Trials by Disease

    Non-small cell lung cancer Breast cancer Plasma cell myeloma Neoplasm Neoplasm malignant Acute myeloid leukaemia Colitis ulcerative Obesity Colorectal cancer metastatic Prostate cancer Crohn's disease Dementia Alzheimer's type Colorectal cancer Ovarian cancer Hepatocellular carcinoma Breast cancer metastatic Dermatitis atopic Asthma Non-small cell lung cancer metastatic Malignant melanoma More trials…
  • Rare Diseases Treatments

    Search Trials by Disease

    Philadelphia positive acute lymphocytic leukaemia Mantle cell lymphoma stage III Lung adenocarcinoma Myelodysplastic syndrome with excess blasts Deafness bilateral Acute graft versus host disease in liver Rett syndrome Dementia with Lewy bodies Arginase deficiency Osteopetrosis Fatty acid oxidation disorder Acute respiratory distress syndrome Arrhythmia Immunoglobulin G4 related disease Gestational trophoblastic tumour More trials…

    Learn about Rare Diseases

    Hereditary motor and sensory neuropathy – Basic Information Progressive multifocal leukoencephalopathy – Life with Disease Haemolytic uraemic syndrome – Diagnostics Myxofibrosarcoma – Life with Disease Familial amyotrophic lateral sclerosis – Trials in Disease Systemic sclerosis pulmonary – Treatment Haemophilia A with anti factor VIII Myelodysplastic syndrome – Life with Disease Haemophagocytic lymphohistiocytosis – Treatment Chondrosarcoma – Life with Disease More diseases
  • Vaccine Clinical Trials
  • Pediatric Clinical Trials
  • Resources for Patients

    Browse Innovative Treatments

    Mk-4830 Povetacicept Aciclovir Human Fibrinogen Hydroxychloroquine Sulfate Remifentanil Azelastine Lysine Aspirin Saruparib Clobetasol Propionate Lumasiran Vutrisiran Nifedipine Tucatinib Batoprotafib Gefurulimab Bjt-778 SARACATINIB F1245/05 Alkaline Phosphatase, Bovine More therapies…

    Learn about Your Condition

    Type 2 diabetes mellitus Pneumothorax Renal cancer recurrent Myeloproliferative neoplasm Systemic infection Tardive dyskinesia Leiomyosarcoma metastatic Procedural haemorrhage Psychological trauma Sinus rhythm Gallbladder cancer Angelman's syndrome Hypoxia Corneal graft failure Progressive multiple sclerosis More diseases
  • Healthy Volunteers
  • Patient Guide
  • Our Partners
  • About Us
  • Contact us
  • Region
    🇪🇺 Europe
    🇦🇹 Austria
    🇭🇷 Croatia
    🇨🇿 Czech Republic
    🇩🇰 Denmark
    🇪🇪 Estonia
    🇫🇮 Finland
    🇫🇷 France
    🇩🇪 Germany
    🇮🇸 Iceland
    🇮🇹 Italy
    🇱🇻 Latvia
    🇱🇹 Lithuania
    🇳🇱 Netherlands
    🇳🇴 Norway
    🇵🇱 Poland
    🇵🇹 Portugal
    🇷🇴 Romania
    🇸🇰 Slovakia
    🇸🇮 Slovenia
    🇪🇸 Spain
    🇸🇪 Sweden

ABM

  • Study of Amivantamab, Pembrolizumab, and Paclitaxel for Patients with Recurrent or Metastatic Head and Neck Squamous Cell Carcinoma

    Recruiting

    1 1 1 1
    Investigated Diseases:
    • Squamous cell carcinoma of head and neck
    Investigated Drugs:
    • Amivantamab
    • Carboplatin
    • Pembrolizumab
    France Germany Poland Spain

  • Study on the Safety of Alprazolam for Treating Long Seizures in Patients Aged 12 and Older

    Recruiting

    3 1
    Investigated Drugs:
    • Alprazolam
    Bulgaria Czechia Germany Hungary Italy Poland +1

  • Study on Dexmedetomidine, Midazolam, and Lorazepam for Treating Acute Agitation in Emergency Psychiatry Patients

    Recruiting

    4 1 1 1
    Investigated Diseases:
    • Agitation
    Investigated Drugs:
    • Lorazepam
    • Dexmedetomidine
    • Midazolam
    Denmark

  • Study of ivosidenib in adults with advanced or metastatic chondrosarcoma with IDH1 mutation who are untreated or have had one prior treatment

    Recruiting

    3 1
    Investigated Diseases:
    • Chondrosarcoma
    Investigated Drugs:
    • Ivosidenib
    Belgium Denmark France Germany Italy The Netherlands +1

  • Study Comparing Trabectedin and Gemcitabine for Patients with Advanced or Metastatic Leiomyosarcoma After Chemotherapy

    Recruiting

    2 1 1 1
    Investigated Diseases:
    • Leiomyosarcoma
    • Leiomyosarcoma metastatic
    Investigated Drugs:
    • Trabectedin
    • Gemcitabine
    Italy

  • Study of cefuroxime and metronidazole to prevent infections after Whipple’s procedure in patients with high risk of bile contamination

    Recruiting

    3 1 1 1
    Investigated Drugs:
    • Cefuroxime
    • Metronidazole
    The Netherlands
Previous Page
1 … 498 499 500 501 502 … 1,653
Next Page

Investigational Drugs in This Location

See which drug candidates are part of clinical trials near you. Click for detailed trial information.

Medical Conditions Being Studied in This Location

Explore diseases currently included in clinical trials near you. Click to view trials and details for each condition.

European Clinical Trials Information Network

The European Clinical Trials Information Network is transforming access to clinical trial information for patients across Europe. By overcoming language barriers, our platform allows everyone, regardless of their native language, to easily find relevant and comprehensible clinical trial data. This innovative service connects patients to cutting-edge treatments, creating a unified European community where health and progress transcend borders.

This service is not affiliated with the European Commission, the EMA, or the official CTIS system. Most information comes from publicly available international clinical-trial registries, supplemented by data from academic centres, national regulators, and commercial sponsors. We aim to keep all content accurate and up to date.

Explore the full ecosystem of clinical research in Europe.

The information provided on this website is mainly derived from international public clinical trial databases (CTIS.eu). In addition, we are including supplementary sources, such as information provided by academic centers and national regulators, as well as information supplied by commercial sponsors (pharmaceutical companies and contract research organizations). We try to ensure that the information provided is accurate and up to date.

Certain content and visual elements on this website have been generated or enhanced using artificial intelligence (AI).

The website is published by:
CTIN POLAND sp. z o.o.
with its registered office in Warsaw,
ul. rtm. Witolda Pileckiego 67/109,
02-781 Warsaw, Poland,
entered in the Register of Entrepreneurs of the National Court Register under KRS number 0001111334,
REGON: 528919042, NIP (Tax ID): 9512598637
Contact us

© 2026 CTIN Poland

Privacy Policy

Terms and Conditions

Contact

For Sites and Sponsors

Clinical Trial Locations

We use cookies

The website uses cookies to ensure the proper functioning of the site and to analyze internet traffic. Some cookies are essential for using the service and do not require consent. You can accept all cookies or use only the essential ones. Data is processed in accordance with our Privacy Policy. You have the right to withdraw your consent, access, rectify, delete, or limit the processing of your data at any time.
Numer nieprawidłowy!
Numer nieprawidłowy!